Year: 2019
Type: dissertation
Abstract: Wound infections present major health problems worldwide. It has been revealed that \nbacterial biofilm communities frequently colonise chronic wounds.Biofilms with Multidrugresistant organisms (MDRO) such as Methicillin Resistant Staphylococcus aureus (MRSA) \nand Pseudomonas aeruginosa are increasingly implicated in chronic wound infections. The \nlimited therapeutic options are further compromised by the fact that wound-infecting bacteria \noften co-exist within a polymicrobial biofilm community, which enhances bacterial tolerance \nor resistance to antimicrobials. The polyunsaturated fatty acid (PUFA) compounds including \nDocosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA) offer both \nimmunomodulatory and antimicrobial properties that could enhance wound healing. \n \nThis study evaluated the activity and efficiency of these compounds against wound \npathogens and compared them to common antibiotics Linezolid (LZD) and vancomycin \n(VAN). Standard antibiotic sensitivity assays were used to determine the ability of PUFAs to \ninhibit growth and biofilm formation. Most activity was observed against S. aureus strains. \nThe bacteriostatic activity (minimum inhibitory concentration - MIC) of DHA and EPA for S. \nAureus SA3 and P. aeruginosa PA01 was 65 and 117 μgml-1 \nrespectively. Meanwhile, the bacteriocidal activity required higher concentrations (MBC) of 260 and 468 μgml-1 \nrespectively. The antibiotic LZD was most active against Gram positive bacteria (MIC range \nfrom 1.9 µg ml-1 to 3.9 µg ml-1). However, vancomycin was the most potent biofilm disrupter, with MBECs ranging from 5-12.5 µg ml-1. These concentrations were 35-fold lower than the MBECs recorded for linezolid (125 -500 µg ml-1). Considerably higher concentrations of \nPUFA compounds were required to disrupt biofilms. The MBECs of DHA ranged between \n750 and 3125 µg ml-1. EPA was found to be more disruptive than DHA (MBECs ranging \nbetween 500 and 2250 µg ml-1), while the MBECs of combination treatment with both \nPUFAs (DHA+EPA) ranged from 750 - 1500 µg ml-1. \n \nThe antimicrobial activity of different concentrations of PUFAs was further \nAssessed by monitoring inhibition of growth of a clinical wound isolate of S. aureus (SA3)for \n24 h. PUFAs were shown to differentially affect expression of global gene regulators using \nRT-qPCR. DHA and EPA were found to upregulate agrA and icaA but downregulate sarA at \nthe same concentrations and exposure times. \n \nTwo different infection models were used to assess the activity of PUFAs in vivo (Galleria mellonella) and on ex-vivo skin compared to common antibiotics (LZD and \nVAN). PUFAs reduced virulence of SA3 in G.mellonella, protecting the larvae from death. \nFurthermore, prolonged exposure to sub-inhibitory concentrations affected growth \nEfficiency of SA3 in vivo. Whole genome sequencing of parent vs PUFA and antibiotics adapted strains of S. aureus SA3 revealed some common mutations in sarA and clfB genes, that \nmay contribute to altered virulence and susceptibility to treatment. Preliminary studies with \nthe ex-vivo skin model suggested that this may be a useful system for testing the efficacy of \nantimicrobial compounds for wound-treatment. Differences in SA3 survival and growth were \nmeasurable in the presence of PUFAs or absence of PUFAs. \n \nIn conclusion, PUFAs (DHA and EPA) showed weak antimicrobial activity \ncompared to common antibiotics against common wound-associated bacteria. However, this \nstudy shows evidence that PUFAs have additional desirable properties, including disruption \nof global gene regulation, reduction of virulence and low potential to promote development \nof resistance.
Author: Eshlak
Institution: University of Salford
Language: English
Topic: Wound Healing and Treatments
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: polyunsaturated fatty acids, docosahexaenoic acid, eicosapentaenoic acid, chronic wound infection, bacterial biofilms, biofilm eradication, multidrug-resistant organisms, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, linezolid, vancomycin, minimum biofilm eradication concentration, minimum inhibitory concentration
Open Access status: green
OpenAlex ID: W2948184954
